Allergy Clinical Trials

22 recruiting

Allergy Trials at a Glance

76 actively recruiting trials for allergy are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Madrid, Palo Alto, and Boston. Lead sponsors running allergy studies include National Institute of Allergy and Infectious Diseases (NIAID), Inmunotek S.L., and Chinese University of Hong Kong.

Treatments under study

About Allergy Clinical Trials

Looking for clinical trials for Allergy? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Allergy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Allergy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 76 trials

Recruiting
Early Phase 1

LYmph Node eXamination in Cat Allergen Immunotherapy

Allergy
National Institute of Allergy and Infectious Diseases (NIAID)16 enrolled1 locationNCT07447869
Recruiting
Not Applicable

Allergy Delabeling in Antibiotic Stewardship - Intervention

Hematologic MalignancyBeta Lactam Allergy
Ebbing Lautenbach3,800 enrolled1 locationNCT07133074
Recruiting
Phase 2

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

Milk and/or Peanut Allergy
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT03835767
Recruiting
Not Applicable

Hydrolysed Rice Formula Study

Cow's Milk Protein Allergy
Nutricia UK Ltd86 enrolled2 locationsNCT06288503
Recruiting

Comparison of Skin Prick Testing, Extract-specific IgE Antibody Testing and Component Resolved Diagnosis in Diagnosing of Legume Allergy

Food Allergy Suspected
University Hospital Pilsen100 enrolled1 locationNCT06923878
Recruiting
Phase 2

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

Ig-E Mediated Food Allergy
RAPT Therapeutics, Inc.100 enrolled21 locationsNCT07220811
Recruiting
Phase 4

Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation

ImmunotherapyAllergyVenom Allergy
Murdoch Childrens Research Institute100 enrolled3 locationsNCT06935890
Recruiting
Phase 3

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Allergy
DBV Technologies480 enrolled90 locationsNCT07003919
Recruiting

GRASS (Grass MATA MPL Real-world Assessment Study)

Grass Pollen Allergy
Allergy Therapeutics1,000 enrolled1 locationNCT07412990
Recruiting

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

Allergy
Stanford University2,500 enrolled1 locationNCT04828603
Recruiting

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

Allergy and Immunology
University Hospital, Toulouse1,376 enrolled2 locationsNCT04751760
Recruiting

Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort Study

Cow's Milk Protein Allergy
Universitaire Ziekenhuizen KU Leuven30 enrolled5 locationsNCT07448740
Recruiting
Phase 1Phase 2

Tolerance Results and Immune Mechanisms in Cow´s Milk and/or Hen´s Egg Allergic Children Following Natural Evolution or Oral Immunotherapy

Food Allergy in Children
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa68 enrolled1 locationNCT07419243
Recruiting
Not Applicable

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

Allergic Contact DermatitisMetal Allergy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS280 enrolled2 locationsNCT06529913
Recruiting
Phase 2Phase 3

Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study

Food Allergy in ChildrenMilk Allergy
Pablo Rodríguez del Rio40 enrolled1 locationNCT06976775
Recruiting
Not Applicable

Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing

Allergy
University Hospital, Montpellier100 enrolled1 locationNCT07402200
Recruiting
Not Applicable

Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy

IgE-Mediated Cow Milk Allergy
Health and Happiness Research Limited29 enrolled1 locationNCT07197814
Recruiting
Phase 4

Steroid Use in Treatment of Allergic Reactions to Food

AnaphylaxisAnaphylactic ReactionAllergy in Children
Johannes Trueck160 enrolled2 locationsNCT07341776
Recruiting

SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

Gut MicrobiotaFood HypersensitivityCow's Milk Protein Allergy (CMPA)+1 more
Outcomes'1041 enrolled13 locationsNCT07342621
Recruiting

Analysis of the Role of IgE Proteoforms in Health and Disease

AnaphylaxisHealthy ControlMastocytosis+6 more
KU Leuven200 enrolled1 locationNCT07328178